Koonz, McKenney, Johnson & DePaolis LLP
District of Columbia D.C. (202) 796-3291
Virginia VA (703) 498-2928
Maryland MD (301) 637-4614
se habla español
Call today for your free consultation
se habla español
Experienced at winning cases for people who need justice
Washington DC Personal injury law firm

Defective Drugs and Drug Recalls

Posted on February 20, 2012 to

Roger Johnson

If a defective prescription drug has the potential to harm consumers, the Food and Drug Administration (FDA) is the regulatory body that issues a recall notice to the public. The purpose of the recall is to get the drug off the market as quickly as possible. Drug recalls can be voluntary by the drug manufacturer, at the FDA’s request or by an FDA order.

The FDA classifies drug recalls as Class 1, Class 2 or Class 3 recalls. The distinction between the classes is as follows:

  • A Class 1 recall means there is a reasonable probability that using the drug will cause serious adverse health consequences or death
  • A Class 2 recall means that using the drug may cause temporary or medical reversible adverse health consequences, or the probability of serious adverse health consequences is remote
  • A Class 3 recall means that using the drug is not likely to cause adverse health consequences

A lesser classification is a “market withdrawal,” which occurs for minor violations, such as tampering, without evidence of manufacturing defects. Market withdrawals are not subject to FDA legal action.

Have you suffered injuries from a defective drug?

Koonz, McKenney, Johnson, DePaolis & Lightfoot, L.L.P.

Maryland, Washington, D.C. and Virginia Injury Attorneys

Approved by attorney Roger Johnson.